BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33363385)

  • 1. Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.
    Zhang N; Shi J; Shi X; Chen W; Liu J
    Onco Targets Ther; 2020; 13():12797-12809. PubMed ID: 33363385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene mutations of esophageal squamous cell carcinoma based on next-generation sequencing.
    Wang L; Jia YM; Zuo J; Wang YD; Fan ZS; Feng L; Zhang X; Han J; Lyu WJ; Ni ZY
    Chin Med J (Engl); 2021 Feb; 134(6):708-715. PubMed ID: 33725708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics and multivariate survival analysis of 43 patients with locally advanced or metastatic esophageal squamous cell carcinoma.
    Zhou X; Bao W; Zhu X; Wang D; Zeng P; Xia G; Xing M; Zhan Y; Yan J; Yuan M; Zhao Q
    J Thorac Dis; 2024 Mar; 16(3):1843-1853. PubMed ID: 38617776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
    Song B; Cui H; Li Y; Cheng C; Yang B; Wang F; Kong P; Li H; Zhang L; Jia Z; Bi Y; Wang J; Zhou Y; Liu J; Wang J; Zhao Z; Zhang Y; Hu X; Shi R; Yang J; Liu H; Yan T; Li Y; Xu E; Qian Y; Xi Y; Guo S; Chen Y; Wang J; Li G; Liang J; Jia J; Chen X; Guo J; Wang T; Zhang Y; Li Q; Wang C; Cheng X; Zhan Q; Cui Y
    Oncotarget; 2016 Jan; 7(3):3599-613. PubMed ID: 26528858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma.
    Naseri A; Salehi-Pourmehr H; Majidazar R; Seraji P; Rezazadeh-Gavgani E; Zehtabi M; Kiani-Kezbin H; Salehnia F; Hassannezhad S; Hajikamanj A; Raeisi M
    J Gastrointest Cancer; 2022 Dec; 53(4):1040-1049. PubMed ID: 34611831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.
    Dutta M; Nakagawa H; Kato H; Maejima K; Sasagawa S; Nakano K; Sasaki-Oku A; Fujimoto A; Mateos RN; Patil A; Tanaka H; Miyano S; Yasuda T; Nakai K; Fujita M
    PeerJ; 2020; 8():e9294. PubMed ID: 32617189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History.
    He W; Leng X; Yang Y; Peng L; Shao Y; Li X; Han Y
    Onco Targets Ther; 2020; 13():8795-8802. PubMed ID: 32943884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma.
    Zou B; Guo D; Kong P; Wang Y; Cheng X; Cui Y
    Front Mol Biosci; 2021; 8():792779. PubMed ID: 35127817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
    Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
    ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
    Hong MH; Heo SG; Lee YG; Kim HS; Park KU; Kim HG; Ko YH; Chung IJ; Min YJ; Kim MK; Kim KR; Yoo J; Kim TM; Kim HR; Cho BC
    Cancer; 2020 Oct; 126(20):4521-4531. PubMed ID: 32749686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma.
    Xu X; Wang Y; Bai Y; Lu J; Guo Y; Wang X; Rong L; Tang J; Ma X; Ma J; Zhang L
    Front Immunol; 2022; 13():1001173. PubMed ID: 36119057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic landscape of esophageal squamous cell carcinoma.
    Gao YB; Chen ZL; Li JG; Hu XD; Shi XJ; Sun ZM; Zhang F; Zhao ZR; Li ZT; Liu ZY; Zhao YD; Sun J; Zhou CC; Yao R; Wang SY; Wang P; Sun N; Zhang BH; Dong JS; Yu Y; Luo M; Feng XL; Shi SS; Zhou F; Tan FW; Qiu B; Li N; Shao K; Zhang LJ; Zhang LJ; Xue Q; Gao SG; He J
    Nat Genet; 2014 Oct; 46(10):1097-102. PubMed ID: 25151357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort.
    Mangalaparthi KK; Patel K; Khan AA; Manoharan M; Karunakaran C; Murugan S; Gupta R; Gupta R; Khanna-Gupta A; Chaudhuri A; Kumar P; Nair B; Kumar RV; Prasad TSK; Chatterjee A; Pandey A; Gowda H
    Front Oncol; 2020; 10():1457. PubMed ID: 32974170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.
    Wang L; Shan L; Zhang S; Ying J; Xue L; Yuan Y; Xie Y; Lu N
    PLoS One; 2014; 9(7):e103021. PubMed ID: 25054828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.
    Hou J; Jiang D; Zhang J; Gavine PR; Xu S; Liu Y; Xu C; Huang J; Tan Y; Wang H; Lu Y; Zheng L; Hou Y; Tan L
    Hum Pathol; 2014 Feb; 45(2):352-8. PubMed ID: 24360885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.